This webinar will discuss the role of ablative radiotherapy for breast cancer in patients who are not candidates for surgery due to age, comorbidities, inoperable primary tumors, or personal choice. We will review our retrospective experience, present findings from a recently completed dose-escalation trial, and outline plans for a large multicenter randomized controlled trial
